121 related articles for article (PubMed ID: 17893233)
1. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia.
Matoso A; Zhou Z; Hayama R; Flesken-Nikitin A; Nikitin AY
Carcinogenesis; 2008 Mar; 29(3):620-8. PubMed ID: 17893233
[TBL] [Abstract][Full Text] [Related]
2. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.
Pei XH; Bai F; Smith MD; Xiong Y
Cancer Res; 2007 Apr; 67(7):3162-70. PubMed ID: 17409423
[TBL] [Abstract][Full Text] [Related]
3. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
[TBL] [Abstract][Full Text] [Related]
5. Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Stålberg P; Santesson M; Ekeblad S; Lejonklou MH; Skogseid B
Surgery; 2006 Dec; 140(6):921-9; discussion 929-31. PubMed ID: 17188139
[TBL] [Abstract][Full Text] [Related]
6. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
[TBL] [Abstract][Full Text] [Related]
7. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
11. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.
Jiang XH; Lu JL; Cui B; Zhao YJ; Wang WQ; Liu JM; Fang WQ; Cao YN; Ge Y; Zhang CX; Casse H; Li XY; Ning G
Endocr Relat Cancer; 2007 Dec; 14(4):1073-9. PubMed ID: 18045958
[TBL] [Abstract][Full Text] [Related]
12. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
13. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
14. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.
Libutti SK; Crabtree JS; Lorang D; Burns AL; Mazzanti C; Hewitt SM; O'Connor S; Ward JM; Emmert-Buck MR; Remaley A; Miller M; Turner E; Alexander HR; Arnold A; Marx SJ; Collins FS; Spiegel AM
Cancer Res; 2003 Nov; 63(22):8022-8. PubMed ID: 14633735
[TBL] [Abstract][Full Text] [Related]
16. Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice.
Loffler KA; Biondi CA; Gartside MG; Serewko-Auret MM; Duncan R; Tonks ID; Mould AW; Waring P; Muller HK; Kay GF; Hayward NK
Oncogene; 2007 Jun; 26(27):4009-17. PubMed ID: 17173065
[TBL] [Abstract][Full Text] [Related]
17. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
[TBL] [Abstract][Full Text] [Related]
18. Tumour suppressor menin is essential for development of the pancreatic endocrine cells.
Fontanière S; Duvillié B; Scharfmann R; Carreira C; Wang ZQ; Zhang CX
J Endocrinol; 2008 Nov; 199(2):287-98. PubMed ID: 18772165
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of neuroendocrine tumors.
Duerr EM; Chung DC
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):1-14. PubMed ID: 17382262
[TBL] [Abstract][Full Text] [Related]
20. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
